Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Levi Strauss & Co. (LEVI) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Levi Strauss & Co.Trade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Levi Strauss & Co. vs Zimmer Biomet Holdings Inc — how do they compare? Levi Strauss & Co. trades at $22.73 (market cap $8.75B), while Zimmer Biomet Holdings Inc trades at $97.27 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2.1× Levi Strauss & Co.'s market cap, and Levi Strauss & Co. pays the higher dividend (2.81%). Which is the better fit depends on your goals.

LEVIZBH
Market Cap
$8.75B$18.55B
Sector
Consumer CyclicalHealth
52-Week High
$25.53$107.71
52-Week Low
$17.92$79.58
Enterprise Value
$10.07B$25.61B
Dividend Yield
2.81%0.99%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Levi Strauss & Co.

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver

Read more on LEVI

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH